期刊文献+

瑞德西韦制备工艺中手性杂质的合成

Synthesis of Chiral Impurities in Production Process of Remdesivir
原文传递
导出
摘要 为了增强对瑞德西韦的质量控制,设计合成了其工艺路线中易产生的重要手性杂质,包括(S)-2-[[(S)-[[(2R,3S,4R,5S)-5-(4-氨基吡咯并[2,1-f][1,2,4]三嗪-7-基)-5-氰基-3,4-二羟基四氢呋喃-2-基]甲氧基](苯氧基)磷酰基]氨基]丙酸-2-乙基丁基酯,以及其(S)-2-[(R)-(2R,3S,4R,5R)]-型和(S)-2-[(R)-(2R,3S,4R,5S)]-型光学异构体,这些化合物的结构通过MS和NMR确证。本工艺条件温和、收率高、无需手性分离,适合实验室规模制备。 To improve quality control of remdesivir,the key chiral impurities easily generated in the production process of remdesivir were designed and synthesized.The structures of these compounds included(S)-2-ethylbutyl 2-[[(S)-[[(2R,3S,4R,5S)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]-methoxy](phenoxy)phosphoryl]amino]propanoate,(S)-2-[(R)-(2R,3S,4R,5R)]-type and(S)-2-[(R)-(2R,3S,4R,5S)]-type optical isomers were confirmed by MS and NMR.This method was suitable for laboratory synthesis due to its mild reaction conditions,high yield and no need for chiral separation.
作者 方治坤 朱阳 姚长亮 FANG Zhikun;ZHU Yang;YAO Changliang(Central Institute of Shanghai Pharmaceuticals Holding Co.,Ltd.,Shanghai 201203)
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2022年第8期1141-1147,共7页 Chinese Journal of Pharmaceuticals
关键词 瑞德西韦 新型冠状病毒肺炎 手性杂质 remdesivir corona virus disease 2019(COVID-19) chiral impurity

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部